Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 773)
Posted On: 01/13/2023 4:06:21 PM
Post# of 153990
Posted By: CGC
Re: Giacomo27 #132366
Agree Giacomo27.

Recently discovered a pharmacogenomic testing process- called Genomind. FDA has indicted they believe that pharmacogenomics (the study of the role of the genome in drug response) will play a role in 'identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose.'

In this case- it is primarily focused on mental health- up to 24 genes and about 800 medications. You order the kit online, do a cheek swab and get a report to help your doc understand how your genotype may affect tolerability and/or likelihood of responding to specific therapeutic options. I know 2 people that had life changing improvements when their docs used this testing to ID correct treatments. Am also aware of several folks- patients and mental health docs- that are fighting it tooth and nail.

Ready for the day- when docs can know how individuals metabolize medication across the board as easily as their blood type. "Patient has this much CCR5- so they need this much leronlimab..."

Science Behind Genomind













(7)
(1)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site